Table 5.
TOP 10 of OTC anthroposophy for privately insured people in 2016
| Product name | Field of application | Packages | Billing amounta,b | ||
|---|---|---|---|---|---|
| in Thousand | in % of antrophosophy | in Million € | in % of anthroposophy | ||
| ISCADOR | Mistletoe therapies as an addition to tumor therapy | 15.3 | 2.2 | 1.4 | 11.3 |
| HELIXOR | Mistletoe therapies as an addition to tumor therapy | 10.6 | 1.5 | 1.1 | 8.8 |
| EUPHRASIA | Conjunctivities, miscellaneous | 73.2 | 10.7 | 0.9 | 6.7 |
| ABNOBAVISCUM | Mistletoe therapies as an addition to tumor therapy | 6.5 | 0.9 | 0.6 | 5.0 |
| NEURODORON | Nervous exhaustion and metabolic weakness | 14.3 | 2.1 | 0.3 | 2.3 |
| ISCUCIN | Mistletoe therapies as an addition to tumor therapy | 4.8 | 0.7 | 0.3 | 2.1 |
| AURUM | Neurasthenia, vegetative dystonia, depressive state, lack of concentration, weakness of memory | 16.2 | 2.4 | 0.3 | 2.0 |
| ACONIT | Joint or muscle problem, earache | 21.6 | 3.2 | 0.2 | 1.9 |
| HEPATODORON | Stimulation of liver or bowel action | 8.8 | 1.3 | 0.2 | 1.6 |
| BRYOPHYLLUM | Insomnia, irritable bladder | 8.7 | 1.3 | 0.2 | 1.5 |
a The billing amounts are not identical with the benefit amount (the cost reimbursement principle within the private health insurance), b The billing amount included aid and self-participation